Back to Search
Start Over
Clinical characteristics and treatment outcomes of natural killer/T-cell lymphoma involving the ocular adnexa.
- Source :
-
The British journal of ophthalmology [Br J Ophthalmol] 2019 Feb; Vol. 103 (2), pp. 269-273. Date of Electronic Publication: 2018 Apr 29. - Publication Year :
- 2019
-
Abstract
- Aims: To evaluate the clinical characteristics and treatment outcomes of natural killer/T-cell lymphoma (NKTL) involving the ocular adnexa.<br />Methods: Retrospective, comparative, observational case series. A total of 350 patients with NKTL, including 27 patients with NKTL involving the ocular adnexa from 1999 to 2016. The patients were grouped into two groups: group 1 comprised patients presenting with ophthalmic symptoms, and group 2 comprised patients presenting with symptoms from other organs but subsequently developed ophthalmic involvement.<br />Results: Group 1 comprised 12 patients (44.4%) and group 2 comprised 15 (55.6%). Mean duration of symptoms in group 1 was 1.8±1.2 months, while the time from diagnosis of NKTL to development of ophthalmic symptoms in group 2 was 45.3±65.6 months. Periorbital swelling was the most common presenting symptom in both groups (83.3% in group 1 and 73.3% in group 2). Symptoms mimicking cellulitis and pseudotumor were present in 50.0% and 16.7% of cases, respectively. The 5-year overall survival rate was 18.5% in group 1 and 26.4% in group 2, while the 5-year progression-free survival rate was 0% and 13.3%, respectively.<br />Conclusions: Our series is to our knowledge the largest cohort study on NKTL reported to date and demonstrates that ocular adnexal NKTL is a rare but seriously fatal disease. It is characterised by acute inflammatory signs as present in as many as two-thirds of our patients in this series. It should be considered as a differential diagnosis in patients presenting with rapidly progressing proptosis and diagnosed promptly for optimal management.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Subjects :
- Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Cohort Studies
Disease-Free Survival
Female
Humans
Lymphoma, T-Cell drug therapy
Lymphoma, T-Cell mortality
Male
Maxillary Sinus Neoplasms drug therapy
Maxillary Sinus Neoplasms mortality
Middle Aged
Mouth Neoplasms drug therapy
Mouth Neoplasms mortality
Nose Neoplasms drug therapy
Nose Neoplasms mortality
Orbital Neoplasms drug therapy
Orbital Neoplasms mortality
Retrospective Studies
Survival Rate
Treatment Outcome
Young Adult
Killer Cells, Natural pathology
Lymphoma, T-Cell pathology
Maxillary Sinus Neoplasms pathology
Mouth Neoplasms pathology
Nose Neoplasms pathology
Orbital Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1468-2079
- Volume :
- 103
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The British journal of ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 29706604
- Full Text :
- https://doi.org/10.1136/bjophthalmol-2017-311704